Most Popular
-
1
Yoon pushes for Xi’s visit to firm up ties with China
-
2
Esports legend Faker seeks to lead Korean surge at Asian Games
-
3
[Hello Hangeul] The making of Korean language textbooks featuring BTS
![[Hello Hangeul] The making of Korean language textbooks featuring BTS](//res.heraldm.com/phpwas/restmb_idxmake.php?idx=644&simg=/content/image/2023/09/24/20230924000121_0.jpg&u=)
-
4
Incheon Airport passenger traffic to recover during Chuseok holiday
-
5
Korea’s parental leave benefits lag behind OECD average
-
6
Korea trade volume sees sharp drop among OECD members
-
7
Golden apples: Why fruit prices are national issue in early autumn
-
8
2m Koreans opt out of life-extending treatments
-
9
Chief justice seat at top court left vacant amid Assembly chaos
-
10
BTS' Jungkook to drop new single '3D'
![[Hello Hangeul] The making of Korean language textbooks featuring BTS](http://res.heraldm.com/phpwas/restmb_idxmake.php?idx=644&simg=/content/image/2023/09/24/20230924000121_0.jpg&u=)
Celltrion seeks European approval for anticancer biosimilar
By YonhapPublished : Oct. 12, 2021 - 09:23
South Korean biopharmaceutical firm Celltrion Inc. said Tuesday that it has sought European approval for the sale of its anticancer biosimilar candidate.
The European Medicines Agency will review Celltrion's application to sell CT-P16, which references Switzerland-based Roche Holding's blockbuster pill Avastin.
Avastin, which kills cancer cells by removing blood vessels, is approved to treat numerous cancers, including metastatic colorectal cancer.
Avastin raked in sales of 7.7 trillion won ($6.4 billion) globally last year, and the European Union market alone was sized at 2.2 trillion won.
Celltrion also sought approval with local drug authorities and the US Food and Drug Administration. (Yonhap)
The European Medicines Agency will review Celltrion's application to sell CT-P16, which references Switzerland-based Roche Holding's blockbuster pill Avastin.
Avastin, which kills cancer cells by removing blood vessels, is approved to treat numerous cancers, including metastatic colorectal cancer.
Avastin raked in sales of 7.7 trillion won ($6.4 billion) globally last year, and the European Union market alone was sized at 2.2 trillion won.
Celltrion also sought approval with local drug authorities and the US Food and Drug Administration. (Yonhap)
More from Headlines
![[Herald Interview] S&P economist tells Korea to brace for worst-case scenario with China](http://res.heraldm.com/phpwas/restmb_idxmake.php?idx=652&simg=/content/image/2023/09/25/20230925000680_0.jpg&u=20230925173504)
![[Herald Interview] As a wanderer, Yoshitomo Nara does not confine himself to art](http://res.heraldm.com/phpwas/restmb_idxmake.php?idx=652&simg=/content/image/2023/09/25/20230925000732_0.jpg&u=20230925213145)
![[Today’s K-pop] Seventeen takes down teaser for 11th EP](http://res.heraldm.com/phpwas/restmb_idxmake.php?idx=642&simg=/content/image/2023/09/25/20230925000656_0.jpg&u=20230925173059)
